FindTrial
Sign In

Use of stool cbnaat in diagnosis of pulmonary tuberculosis in children

Utility of stool cartridge based nucleic acid amplification test in the diagnosis of pulmonary tuberculosis in children

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/05/019261
Enrollment
75
Registered
2019-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A15- Respiratory tuberculosis

Interventions

None listed

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Suspected case of Pulmonary Tuberculosis as defined by RNTCP: -Persistent fever without a known cause and/or unremitting cough >2 weeks -Weight loss of > 5% / no weight gain in the past 3 months -H/o contact wit an infectious case of TB

Exclusion criteria

Exclusion criteria: Child who has received Antitubercular therapy including 2nd line drugs for more than 72 hours

Design outcomes

Primary

MeasureTime frame
Outcome Variables Stool CBNAAT positives as a proportion of suspected/MGIT culture confirmed cases of pulmonary TB Timepoint: No follow up—

Secondary

MeasureTime frame
-GA CBNAAT positives as a proportion of suspected/MGIT culture confirmed cases of pulmonary TB -Sensitivity and specificity of Stool and Gastric Aspirate CBNAATTimepoint: No follow up—

Countries

India

Contacts

Public ContactDr Dhrithi Kodethoor

Maulana Azad Medical College

doctoranuragagarwal@gmail.com9810409625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026